Are anti-citrulline autoantibodies better serum markers for rheumatoid arthritis than rheumatoid factor in Thai population?

Rheumatology International

Volumn 30, Issue 6, 2010, Pages 755-759

  Vanichapuntu, Monchand ^a   Phuekfon, Puchaniyada ^b   Suwannalai, Parawee ^a   Verasertniyom, Oravan ^a   Nantiruj, Kanokrat ^a   Janwityanujit, Suchela ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b BHUMIBOL ADULYADEJ HOSPITAL   (Thailand)

Author keywords

Anti citrulline antibodies; Cost effectiveness; Predictive values; Rheumatoid arthritis; Rheumatoid factor

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD CELL COUNT; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE MARKER; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; THAILAND;

ADOLESCENT; ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; CITRULLINE; COHORT STUDIES; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RHEUMATOID FACTOR; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; THAILAND; YOUNG ADULT;

EID: 77951022120     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-1058-5     Document Type: Article

References (13)

1. O'Dell JR (2005) Rheumatoid arthritis: the clinical picture. In: Koopman WJ, Moreland LW (eds) Arthritis and allied conditions: a textbook of rheumatology. Lippincott Williams & Wilkins, Baltimore, pp 1165-1194
2. Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classiWcation of rheumatoid arthritis. Arthritis Rheum 31:315-324. doi:10.1002/art.1780310302
3. Schellekens GA, de Jong BA, van den Hoogen FH et al (1998) Citrulline is an essential constituent of antigenic determinants recognised by rheumatoid arthritis-speciWc autoantibodies. J Clin Invest 101:273-281. doi:10.1172/JCI1316
4. Avouac J, Gossec L, Dougados M (2006) Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systemic literature review. Ann Rheum Dis 65:845-851. doi:10.1136/ard.2006.051391
5. Kroot EJ, de Jong BA, van Leeuwen MA et al (2000) The prognosis value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 43:1831-1835. doi:10.1002/1529- 0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6
6. Nell VP, Machold KP, Stamm TA et al (2005) Autoantibody pro- Wling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis 64:1731-1736. doi:10.1136/ard.2005.035691 (Pubitemid 41667147)
7. Symmons DP (2007) ClassiWcation criteria for rheumatoid arthritis: time to abandon rheumatoid factor? Rheumatology 46:725-726. doi:10.1093/rheumatology/ kel418 (Pubitemid 47061697)
8. Abdel-Nasser AM, Mahmoud MH, El Mansoury TM, Osman AM (2008) Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis. Scand J Rheumatol 37(5):329-336. doi:10.1080/0300974080 2116208
9. Kwok JSY, Hui KH, Lee TL et al (2005) Anti-cyclic citrullinated peptide: diagnostic and prognostic values in juvenile idiopathic arthritis and rheumatoid arthritis in a Chinese population. Scand J Rheumatol 34:359-366. doi:10.1080/03009740510026634 (Pubitemid 41545908)
10. Schellekens GA, Visser H, de Jong BA et al (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43:155-163. doi:10.1002/ 1529-0131(200001)43:1<155: :AID-ANR20>3.0.CO;2-3
11. Mediwak R, Isenberg DA, Schellekens GA, van Venrooij WJ (2001) Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 60:67-68. doi:10.1136/ard.60.1.67 (Pubitemid 32038957)
12. Lee DM, Schur PH (2003) Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis 62:870-874. doi:10.1136/ard.62. 9.870 (Pubitemid 37026499)
13. Quinn MA, Gough AK, Green MJ et al (2006) Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome. Rheumatology (Oxford) 45:478-480. doi:10.1093/rheumatology/kei203